Zacks Investment Research
10 Jul 2026, 22:51 UTC · 2h ago
Ares Capital (ARCC) Exceeds Market Returns: Some Facts to Consider
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

Zacks Investment Research
10 Jul 2026, 22:51 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims
4 claims · each scored for market impact
Ares Capital (ARCC) is currently assigned a Zacks Rank of #4 (Sell). — A 'Sell' rating from a major research provider typically signals a bearish outlook and can trigger selling pressure.
-0.50Ares Capital's expected EPS for the upcoming July 29, 2026 report is $0.47, a 6% decrease year-over-year. — Anticipated earnings declines generally lead to lower investor confidence and downward price pressure.
-0.40Ares Capital's full-year earnings are projected to be $1.9 per share, representing a 5.47% decline from the previous year. — A projected annual earnings contraction suggests a deteriorating fundamental outlook for the company.
-0.30Continue reading
6 related stories
Top 3 movers · tap to explore
Ares Capital's stock closed the most recent trading day at $18.78, an increase of 2.01%. — Short-term price gains provide a minor positive signal, though they contrast with the overall bearish ratings.
Which stocks this story touches
The company has a Zacks Rank of #4 (Sell), and expected EPS is predicted to fall compared to the previous year.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.

Zacks Investment Research
1h ago